Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.
- Redburn Atlantic analyst Timm Schulze-Melander initiated coverage on NVIDIA Corporation NVDA with a Buy rating and announced a price target of $178. Nvidia shares closed at $145.26 on Monday. See how other analysts view this stock.
- Benchmark analyst Matthew Harrigan initiated coverage on VEON Ltd. VEON with a Buy rating and announced a price target of $48. VEON shares closed at $33.17 on Monday. See how other analysts view this stock.
- UBS analyst Eliana Merle initiated coverage on Altimmune, Inc. ALT with a Buy rating and announced a price target of $26. Altimmune shares closed at $7.35 on Monday. See how other analysts view this stock.
- Capital One analyst Dan Guglielmo initiated coverage on FrontView REIT, Inc. FVR with an Overweight rating and announced a price target of $22. FrontView REIT shares closed at $18.97 on Monday. See how other analysts view this stock.
- UBS analyst Eliana Merle initiated coverage on Sagimet Biosciences Inc. SGMT with a Buy rating and announced a price target of $12. Sagimet Biosciences shares closed at $5.85 on Monday. See how other analysts view this stock.
Considering buying NVDA stock? Here’s what analysts think:
Read More:
Market News and Data brought to you by Benzinga APIs
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
